Principal Investigator
Frances Valdes
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251185
Clinical Trial Summary
ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients with Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy with HER2 Blockade
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Breast Cancer
Contact Information
Phone Number
305-243-2647